The fact that transgenic mice with deletion of TNFR1 show a significant decline in microglia activation, BACE1 activity, Aβ pathology, less memory deficits and less neuron loss indeed suggest a role for TNRF1 in the pathogenesis of AD (He et al., 2007). The gene discussed is TNFRSF1A; the disease is Alzheimer disease.